Funding
One Mind Accelerator investment · Biotech

Pangea Bio selected for $100,000 One Mind investment

The company joined One Mind’s 2024 mental health accelerator cohort.

By RoundOS Funding desk

Pangea Bio was selected for a $100,000 investment from One Mind on March 4, 2024.

The company was developing medicines for neurological and neuropsychiatric disorders, drawing on molecules inspired by nature. One Mind’s nine-week accelerator combined investment with mentoring and business development support.

Funding history

One Mind Accelerator investment · This round$100K

Sources

  1. One Mind Accelerator Announces Second Cohort of Mental Health Startupsonemind.org · Mar 4, 2024
  2. pangeabio.com

Similar rounds

All Biotech rounds →
BioGeometry

BioGeometry develops generative AI models and experimental workflows for protein design, drug discovery and enzyme engineering.

UndisclosedSeries A+ · Oct 28, 2026
Atlas Bio

Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions.

$10MSeed · Oct 27, 2026
Atlas Bio

Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions.

$2.5MPreviously undisclosed pre-seed · Oct 27, 2026
Samplix

Samplix develops microfluidic tools for functional single-cell screening.

€3MNew capital alongside bond conversions · Oct 27, 2026

Related